Web Analytics

3 Latest Announced Rounds

$2,265.93M Raised in 95 Funding Rounds in the past 7 Days - View All

Funding Round Profile

AvenCell

start up
United States - Cambridge, Massachusetts
  • 22/10/2024
  • Series B
  • $112,000,000

Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.


Related People

Andrew SchiermeierFounder

Andrew Schiermeier United States - Cambridge, Massachusetts

N/A